ESC Premium Access

Association of baseline disability and major adverse outcomes in patients with atrial fibrillation: an analysis from the SPORTIF trials

Congress Presentation

About the speaker

Associate Professor Marco Proietti

University of Milan, Milan (Italy)
11 presentations
0 follower

12 more presentations in this session

Risk of major gastrointestinal bleed in relation to vascular disease risk in 0.5M UK Biobank participants

Speaker: Doctor I. Hammami (Oxford, GB)

Thumbnail

Anticoagulation strategies based on warfarin or direct oral anticoagulants compared to major hemorrhagic events: the relevance of patients aged 75 years or older.

Speaker: Doctor A. Conti (Massa, IT)

Thumbnail

CHA(2)DS(2)-VASc score calibration in anticoagulated vs non-anticoagulated patients in a healthcare area

Speaker: Doctor A. Baluja (Santiago de Compostela, ES)

Thumbnail

The effect of hypertension and metabolic syndrome on left atrial function in patients with paroxysmal atrial fibrillation undergoing catheter ablation

Speaker: Doctor A. Katbeh (Aalst, BE)

Thumbnail

Nocturnal hypoxemic burden in ambulatory patients with atrial fibrillation: a disease-orientated assessment of sleep-disordered breathing severity.

Speaker: Professor D. Linz (Maastricht, NL)

Thumbnail

Access the full session

Poster Session 1 - Atrial fibrillation, anti-platelet therapy, anticoagulation and bleeding

Speakers: Associate Professor M. Proietti, Doctor I. Hammami, Doctor A. Conti, Doctor A. Baluja, Doctor A. Katbeh...
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb